Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,664.80
(
-0.55%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
109.68
(
2.90%
)
Bitcoin
69,890.92
(
-1.89%
)
News Focus
News Focus

Replies to post #32644 on RespireRx Pharmaceuticals Inc (fka RSPI)

Replies to #32644 on RespireRx Pharmaceuticals Inc (fka RSPI)
icon url

DewDiligence

03/15/10 10:13 AM

#32645 RE: atheroprevent #32644

…the Accord trial tarnished 2 Novartis drugs…

The outcome won’t have a material impact for NVS, however. Diovan is going off-patent soon, and Starlix has never amounted to anything anyhow.